AN OPTIMAL COMBINATION OF SEVERAL BINARY MARKERS BASED ON NEYMAN-PEARSON LEMMA: WITH AN APPLICATION TO IMMUNOHISTOCHEMICAL MARKERS FOR THE DIAGNOSIS OF CLASSICAL HODGKIN LYMPHOMA

被引:1
|
作者
Pourahmad, Saeedeh [1 ,3 ]
Kharrati-Kopaei, Mahmood [2 ]
Hosseini-Moghadam, Zahra [3 ]
Nouri, Sadat [4 ]
Jahromi, Mojgan Akbarzadeh [4 ]
机构
[1] Shiraz Univ Med Sci, Colorectal Res Ctr, Shiraz, Iran
[2] Shiraz Univ, Dept Stat, Shiraz, Iran
[3] Shiraz Univ Med Sci, Dept Biostat, Shiraz, Iran
[4] Shiraz Univ Med Sci, Dept Pathol, Shiraz, Iran
关键词
classical Hodgkin lymphoma; diagnostic marker; likelihood ratio; Neyman-Pearson lemma; ROC curve;
D O I
10.17654/AS048050369
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Combining the results of different binary diagnostic markers to reach maximum area under the receiver operating characteristic (ROC) curve is the aim of the present study. To this end, the Neyman-Pearson lemma is utilized to combine the results of several binary diagnostic markers to obtain an optimum decision rule. The applied procedure has two advantages: (1) no distributional assumptions are considered for diagnostic markers, and (2) the derived rules are optimal in the sense that their ROC curves are maximized at each point. As an application, eleven different subsets of six diagnostic markers of classical Hodgkin lymphoma (CD15, CD20, CD30, CD3, Pax-5 and LCA) are applied. Four best subsets are then selected based on the area under the ROC curve (AUC) and their optimal decision rules are derived at 0.05 error rate.
引用
收藏
页码:369 / 389
页数:21
相关论文
共 13 条
  • [1] GENERALIZATION OF NEYMAN-PEARSON LEMMA AND ITS APPLICATION TO OPTIMAL DISTRIBUTION PROBLEMS
    ONAGA, K
    KAKUSHO, O
    ELECTRONICS & COMMUNICATIONS IN JAPAN, 1972, 55 (12): : 27 - 36
  • [2] GENERALIZATION OF NEYMAN-PEARSON LEMMA AND ITS APPLICATION TO OPTIMAL DISTRIBUTION PROBLEMS.
    Onaga, Kenji
    Kakusho, Osamu
    Electronics and Communications in Japan (English translation of Denshi Tsushin Gakkai Zasshi), 1972, 55 (12): : 27 - 36
  • [3] Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma
    Sanchez-Espiridion, Beatriz
    Martin-Moreno, Ana M.
    Montalban, Carlos
    Medeiros, L. Jeffrey
    Vega, Francisco
    Younes, Anas
    Piris, Miguel A.
    Garcia, Juan F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07): : 1080 - 1084
  • [4] Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases
    Canioni, Danielle
    Deau-Fischer, Benedicte
    Taupin, Pierre
    Ribrag, Vincent
    Delarue, Richard
    Bosq, Jacques
    Rubio, Marie-Therese
    Roux, Damien
    Vasiliu, Viorel
    Varet, Bruno
    Brousse, Nicole
    Hermine, Olivier
    PLOS ONE, 2009, 4 (07):
  • [5] Prognostic significance of immunohistochemical markers in classical Hodgkin lymphoma response to treatment. A study of 59 cases
    Canioni, D
    Deau, B
    Taupin, P
    Bosq, J
    Ribrag, V
    Delarue, R
    Vasiliu, V
    Brousse, N
    Olivier, HZ
    BLOOD, 2005, 106 (11) : 286A - 286A
  • [6] Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers
    Jiang, Peng
    Huang, Jin
    Deng, Ying
    Hu, Jing
    Huang, Zhen
    Jia, Mingzhu
    Long, Jiaojiao
    Hu, Zhuoying
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7395 - 7403
  • [7] Predicting recurrence in endometrial cancer based on a combination of classical parameters and immunohistochemical markers
    Jiang, P.
    Huang, J.
    Hu, Z.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 37 - 37
  • [8] The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
    Zijtregtop, Eline A. M.
    Tromp, Ilse
    Dandis, Rana
    Zwaan, Christian M.
    Lam, King H.
    Meyer-Wentrup, Friederike A. G.
    Beishuizen, Auke
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [9] Prognostic Value of Immunohistochemical Markers in Stage III/IV Classical Hodgkin Lymphoma Treated Frontline in the Lysa EORTC 20012 Randomized Protocol
    Canioni, Danielle
    Brice, Pauline
    Bologna, Serge
    Voillat, Laurent
    Gabarre, Jean
    Casasnovas, Olivier
    Devidas, Alain
    Coiffier, Bertrand
    Aoudjhane, Malek
    Audhuy, Bruno
    Andre, Marc
    Fortpied, Catherine
    Carde, Patrice
    Mounier, Nicolas
    Briere, Josette
    BLOOD, 2018, 132
  • [10] An improved prognostic parameter for non-Hodgkin's lymphoma based on the combination of three serum tumor markers
    Gui, W.
    Wang, T.
    Wang, J.
    Wang, L.
    He, J.
    Yang, B.
    Zhao, Z.
    Zhang, H.
    Zhang, Q.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2008, 23 (04): : 207 - 213